Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-24 3:48 pm Sale | 2021-11-22 | 13D | Acceleron Pharma Inc. XLRN | Avoro Capital Advisors LLC | 0 0.000% | -4,476,100 (Position Closed) | Filing History |
| 2021-11-10 12:24 pm Sale | 2021-11-09 | 13G | Acceleron Pharma Inc. XLRN | FMR LLC | 493,493 0.807% | -4,184,920 (-89.45%) | Filing History |
| 2021-10-05 12:30 pm Purchase | 2021-09-30 | 13D | Acceleron Pharma Inc. XLRN | Avoro Capital Advisors LLC | 4,476,100 7.300% | 4,476,100 (New Position) | Filing History |
| 2021-02-16 12:23 pm Purchase | 2020-12-31 | 13G | Acceleron Pharma Inc. XLRN | T. Rowe Price Associates, Inc. | 5,309,766 8.800% | 1,877,023 (+54.68%) | Filing History |
| 2021-02-10 10:30 am Purchase | 2020-12-31 | 13G | Acceleron Pharma Inc. XLRN | The Vanguard Group | 5,028,578 8.350% | 863,431 (+20.73%) | Filing History |
| 2021-02-08 10:15 am Sale | 2021-02-05 | 13G | Acceleron Pharma Inc. XLRN | FMR LLC | 4,678,413 7.764% | -1,208,250 (-20.53%) | Filing History |
| 2021-01-28 5:55 pm Sale | 2020-12-31 | 13G | Acceleron Pharma Inc. XLRN | BlackRock Inc. BLK | 4,611,814 7.700% | -780,454 (-14.47%) | Filing History |